<DOC>
	<DOCNO>NCT02033590</DOCNO>
	<brief_summary>The objective study prospectively observe clinical economic outcome use SERI® direct-to-implant breast reconstruction .</brief_summary>
	<brief_title>Clinical Economic Outcomes With Use SERI® Surgical Scaffold Direct-to-implant Breast Reconstruction</brief_title>
	<detailed_description />
	<criteria>Be willing undergo immediate breast reconstruction follow skinsparing nipple spar mastectomy healthy , sufficiently thick , wellvascularized skin flap , implantation SERI® Surgical Scaffold breast implant Be female , 18 65 year age time enrollment Have undergo prior radiation treatment study breast ( ) and/or preoperatively evaluate require radiation treatment study breast ( ) course study Have undergo skin reduce mastectomy Have BMI &lt; 17 ≥ 30 Predicted implant weight 500 gram Have know allergy silk Have abscess active infection location within one month prior surgery Be pregnant , lactating , childbearing potential , unwilling use contraceptive method avoid pregnancy throughout study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>